Late-onset clozapine-induced neutropenia treated with lithium
Dusunen Adam: The Journal of Psychiatry and Neurological Sciences · 2019
DOI: 10.14744/dajpns.2019.00011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 2019. Verfasst von Pelin Tas Durmus. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Clozapine is a second-generation antipsychotic drug, proven to be effective in treatment-resistant schizophrenia.Among patients using clozapine; the incidence of neutropenia is approximately 3% and the incidence of agranulocytosis is approximately 1%.This side effect is diminishing after 18 weeks of drug initiation.Here, we present a case of clozapine-induced neutropenia in a schizophrenic patient seen after 7 years of clozapine use and its treatment with lithium supplementation.
Zitieren
APA
Durmus, P. T. (2019). Late-onset clozapine-induced neutropenia treated with lithium. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.14744/dajpns.2019.00011
Vancouver
Durmus PT. Late-onset clozapine-induced neutropenia treated with lithium. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2019. doi:10.14744/dajpns.2019.00011
BibTeX
@article{Durmus2019,
author = {Durmus, Pelin Tas},
title = {Late-onset clozapine-induced neutropenia treated with lithium},
journal = {Dusunen Adam: The Journal of Psychiatry and Neurological Sciences},
year = {2019},
doi = {10.14744/dajpns.2019.00011}
}
EUVIMED